Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Voyager Therapeutics (VYGR) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Voyager Therapeutics (VYGR) over the last 6 years, with Q3 2025 value amounting to $83000.0.

  • Voyager Therapeutics' Tax Provisions rose 9302.33% to $83000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $719000.0, marking a year-over-year decrease of 2037.65%. This contributed to the annual value of $665000.0 for FY2024, which is 5276.99% down from last year.
  • Voyager Therapeutics' Tax Provisions amounted to $83000.0 in Q3 2025, which was up 9302.33% from $15000.0 recorded in Q2 2025.
  • Voyager Therapeutics' 5-year Tax Provisions high stood at $822000.0 for Q4 2023, and its period low was -$177000.0 during Q3 2023.
  • For the 3-year period, Voyager Therapeutics' Tax Provisions averaged around $200727.3, with its median value being $43000.0 (2024).
  • As far as peak fluctuations go, Voyager Therapeutics' Tax Provisions tumbled by 9801.14% in 2024, and later skyrocketed by 16428.57% in 2025.
  • Over the past 3 years, Voyager Therapeutics' Tax Provisions (Quarter) stood at $822000.0 in 2023, then dropped by 28.95% to $584000.0 in 2024, then plummeted by 85.79% to $83000.0 in 2025.
  • Its Tax Provisions stands at $83000.0 for Q3 2025, versus $15000.0 for Q2 2025 and $37000.0 for Q1 2025.